Cytek Biosciences Reports Second Quarter 2023 Financial Results

FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, 2023.

Related Keywords

Fremont ,California ,United States ,China ,Stephanie Olsen ,Cytek Bioscience ,Pauld Goodson ,Cytek Biosciences ,Wenbin Jiang ,Twitter ,Exchange Commission ,Cytek Biosciences Inc ,Securities Exchange ,Linkedin ,European Union ,Lages Associates ,Biosciences Inc ,Luminex Corporation ,Cytek Aurora Cell Sorter ,Full Spectrum Profiling ,Northern Lights ,Regarding Use ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Cytek Bioscience Quarterly Report ,Cytek Bioscience Annual Report ,Relations Contact ,Region ,